Work

Nivolumab monotherapy in patients with advanced gastric or gastroesophageal junction (GEJ) cancer and 2 or more prior treatment regimens: Sub-analysis of the CheckMate 032 study

Year: 2017

Type: article

Source: Annals of Oncology

DOI: 10.1093/annonc/mdx262.006

Authors: Patrick Ott, Emiliano Calvo, Padmanee Sharma, Dirk Jaeger, Paolo Ascierto, Ian Chau, Johanna Bendell, Katriina Peltola, Matthew Taylor, Marina Tschaika, Cecile Dorange, Yelena Janjigian, Dung Le

Institutions: Dana-Farber Cancer Institute, The University of Texas MD Anderson Cancer Center, University Hospital Heidelberg, National Center for Tumor Diseases, Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale", Royal Marsden Hospital, Sarah Cannon, Tennessee Oncology, Helsinki University Hospital, Oregon Health & Science University, Bristol-Myers Squibb (United States), Memorial Sloan Kettering Cancer Center, Johns Hopkins University, Sidney Kimmel Comprehensive Cancer Center

Language: English

Topic: Cancer Immunotherapy and Biomarkers

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

OpenAlex ID: W2729499427

FWCI: 0.433

Cites:

Cited by: 4

Related to: 10